Hepatitis C virus NS3/4A quasispecies diversity in acute hepatitis C infection in HIV-1 co-infected patients

Journal of Viral Hepatitis

Volumn 21, Issue 6, 2014, Pages

  Nevot, M ^a   Boesecke, C ^b   Parera, M ^a   Andres C ^a   Franco, S ^a   Revollo, B ^a   Ingiliz, P ^c   Tural, C ^a   Clotet, B ^a   Rockstroh, J K ^b   Martinez, M A ^a  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^b UNIVERSITY HOSPITAL BONN   (Germany)

^c Medical Center for Infectious Diseases (MIB)   (Germany)

Author keywords

acute infection; catalytic efficiency; HCV; HIV co infection; protease; quasispecies

Indexed keywords

BOCEPREVIR; NONSTRUCTURAL PROTEIN 3; NONSTRUCTURAL PROTEIN 4A; PEGINTERFERON; RIBAVIRIN; TELAPREVIR; CARRIER PROTEIN; NS3 PROTEIN, HEPATITIS C VIRUS; NS4A COFACTOR PEPTIDE, HEPATITIS C VIRUS; VIRUS PROTEIN; VIRUS RNA;

ACUTE HEPATITIS; ACUTE HEPATITIS C INFECTION; ARTICLE; CLINICAL ARTICLE; CLONE; CONTROLLED STUDY; GENETIC VARIABILITY; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; MALE; MEN WHO HAVE SEX WITH MEN; MUTATION; NUCLEOTIDE SEQUENCE; PHYLOGENY; PRIORITY JOURNAL; VIRUS TRANSMISSION; CLASSIFICATION; CLUSTER ANALYSIS; COMPLICATION; DNA SEQUENCE; ENZYMOLOGY; GENETICS; HEPACIVIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ISOLATION AND PURIFICATION; METABOLISM; MOLECULAR EPIDEMIOLOGY; MOLECULAR GENETICS; PROTEIN DEGRADATION; VIROLOGY;

CARRIER PROTEINS; CLUSTER ANALYSIS; GENETIC VARIATION; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HIV INFECTIONS; HIV-1; HUMANS; MALE; MOLECULAR EPIDEMIOLOGY; MOLECULAR SEQUENCE DATA; PHYLOGENY; PROTEOLYSIS; RNA, VIRAL; SEQUENCE ANALYSIS, DNA; VIRAL NONSTRUCTURAL PROTEINS;

EID: 84901004239     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/jvh.12254     Document Type: Article

References (34)

1. Boesecke C, Wedemeyer H, Rockstroh JK,. Diagnosis and treatment of acute hepatitis C virus infection. Infect Dis Clin North Am 2012; 26 (4): 995-1010.
2. van de Laar T, Pybus O, Bruisten S, et al,. Evidence of a large, international network of HCV transmission in HIV-positive men who have sex with men. Gastroenterology 2009; 136 (5): 1609-1617.
3. Bowen DG, Walker CM,. Adaptive immune responses in acute and chronic hepatitis C virus infection. Nature 2005; 436 (7053): 946-952. (Pubitemid 41191670)
4. Soriano V, Mocroft A, Rockstroh J, et al,. Spontaneous viral clearance, viral load, and genotype distribution of hepatitis C virus (HCV) in HIV-infected patients with anti-HCV antibodies in Europe. J Infect Dis 2008; 198 (9): 1337-1344.
5. Thomson EC, Nastouli E, Main J, et al,. Delayed anti-HCV antibody response in HIV-positive men acutely infected with HCV. AIDS 2009; 23 (1): 89-93.
6. Ballesteros AL, Franco S, Fuster D, et al,. Early HCV dynamics on Peg-interferon and ribavirin in HIV/HCV co-infection: indications for the investigation of new treatment approaches. AIDS 2004; 18 (1): 59-66. (Pubitemid 38402318)
7. EASL. EASL Clinical Practice Guidelines: management of hepatitis C virus infection. J Hepatol 2011; 55 (2): 245-264.
8. Fierer DS, Dieterich DT, Fiel MI, et al,. Rapid Progression to Decompensated Cirrhosis, Liver Transplant, and Death in HIV-Infected Men After Primary Hepatitis C Virus Infection. Clin Infect Dis 2013; 56 (7): 1038-1043.
9. Foy E, Li K, Wang C, et al,. Regulation of interferon regulatory factor-3 by the hepatitis C virus serine protease. Science 2003; 300 (5622): 1145-1148. (Pubitemid 36583099)
10. Li K, Foy E, Ferreon JC, et al,. Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF. Proc Natl Acad Sci USA 2005; 102 (8): 2992-2997. (Pubitemid 40299904)
11. Meylan E, Curran J, Hofmann K, et al,. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 2005; 437 (7062): 1167-1172. (Pubitemid 41509355)
12. Morikawa K, Lange CM, Gouttenoire J, et al,. Nonstructural protein 3-4A: the Swiss army knife of hepatitis C virus. J Viral Hepat 2011; 18 (5): 305-315.
13. Lemon SM,. Induction and evasion of innate antiviral responses by hepatitis C virus. J Biol Chem 2010; 285 (30): 22741-22747.
14. Sarrazin C, Hezode C, Zeuzem S, Pawlotsky JM,. Antiviral strategies in hepatitis C virus infection. J Hepatol 2012; 56 (Suppl 1): S88-S100.
15. Martell M, Esteban JI, Quer J, et al,. Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution. J Virol 1992; 66 (5): 3225-3229.
16. Mas A, Lopez-Galindez C, Cacho I, Gomez J, Martinez MA,. Unfinished stories on viral quasispecies and Darwinian views of evolution. J Mol Biol 2010; 397 (4): 865-877.
17. Pawlotsky JM, Pellerin M, Bouvier M, et al,. Genetic complexity of the hypervariable region 1 (HVR1) of hepatitis C virus (HCV): influence on the characteristics of the infection and responses to interferon alfa therapy in patients with chronic hepatitis C. J Med Virol 1998; 54 (4): 256-264. (Pubitemid 28185417)
18. Aparicio E, Franco S, Parera M, et al,. Complexity and catalytic efficiency of hepatitis C virus (HCV) NS3 and NS4A protease quasispecies influence responsiveness to treatment with pegylated interferon plus ribavirin in HCV/HIV-coinfected patients. J Virol 2011; 85 (12): 5961-5969.
19. Franco S, Parera M, Aparicio E, Clotet B, Martinez MA,. Genetic and catalytic efficiency structure of an HCV protease quasispecies. Hepatology 2007; 45 (4): 899-910. (Pubitemid 46631559)
20. Tamura K, Dudley J, Nei M, Kumar S,. MEGA4: molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol 2007; 24 (8): 1596-1599. (Pubitemid 47236692)
21. Wolinsky SM, Korber BT, Neumann AU, et al,. Adaptive evolution of human immunodeficiency virus-type 1 during the natural course of infection. Science 1996; 272 (5261): 537-542. (Pubitemid 26138195)
22. Kuiken C, Yusim K, Boykin L, Richardson R,. The Los Alamos hepatitis C sequence database. Bioinformatics 2005; 21 (3): 379-384. (Pubitemid 40246609)
23. Martinez MA, Clotet B,. Genetic screen for monitoring hepatitis C virus NS3 serine protease activity. Antimicrob Agents Chemother 2003; 47 (5): 1760-1765. (Pubitemid 36548570)
24. Parera M, Martrus G, Franco S, Clotet B, Martinez MA,. Canine hepacivirus NS3 serine protease can cleave the human adaptor proteins MAVS and TRIF. PLoS ONE 2012; 7 (8): e42481.
25. Bull RA, Luciani F, McElroy K, et al,. Sequential bottlenecks drive viral evolution in early acute hepatitis C virus infection. PLoS Pathog 2011; 7 (9): e1002243.
26. Pfafferott K, Gaudieri S, Ulsenheimer A, et al,. Constrained pattern of viral evolution in acute and early HCV infection limits viral plasticity. PLoS ONE 2011; 6 (2): e16797.
27. Vogel M, Page E, Boesecke C, et al,. Liver fibrosis progression after acute hepatitis C virus infection in HIV-positive individuals. Clin Infect Dis 2012; 54 (4): 556-559.
28. Matthews GV, Pham ST, Hellard M, et al,. Patterns and characteristics of hepatitis C transmission clusters among HIV-positive and HIV-negative individuals in the Australian trial in acute hepatitis C. Clin Infect Dis 2011; 52 (6): 803-811.
29. Prokunina-Olsson L, Muchmore B, Tang W, et al,. A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus. Nat Genet 2013; 45 (2): 164-171.
30. Sarasin-Filipowicz M, Oakeley EJ, Duong FH, et al,. Interferon signaling and treatment outcome in chronic hepatitis C. Proc Natl Acad Sci USA 2008; 105 (19): 7034-7039. (Pubitemid 351754525)
31. Lau DT, Negash A, Chen J, et al,. Innate Immune Tolerance and the Role of Kupffer Cells in Differential Responses to Interferon Therapy Among Patients With HCV Genotype 1 Infection. Gastroenterology 2013; 144 (2): 402-413. e12.
32. Urban T, Charlton MR, Goldstein DB,. Introduction to the genetics and biology of interleukin-28B. Hepatology 2012; 56 (1): 361-366.
33. Sherman KE, Rouster SD, Stanford S, et al,. Hepatitis C virus (HCV) quasispecies complexity and selection in HCV/HIV-coinfected subjects treated with interferon-based regimens. J Infect Dis 2010; 201 (5): 712-719.
34. Chary A, Winters MA, Kottilil S, Murphy AA, Polis MA, Holodniy M,. Impact of interferon-ribavirin treatment on hepatitis C virus (HCV) protease quasispecies diversity in HIV- and HCV-coinfected patients. J Infect Dis 2010; 202 (6): 889-893.